These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2333043)

  • 1. Effects of gold and silver backings on the dose rate around an 125I seed.
    Cygler J; Szanto J; Soubra M; Rogers DW
    Med Phys; 1990; 17(2):172-8. PubMed ID: 2333043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of lead, gold, and silver backings on dose near 125I seeds.
    Meli JA; Motakabbir KA
    Med Phys; 1993; 20(4):1251-6. PubMed ID: 8413037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy with various seed models.
    Thomson RM; Rogers DW
    Med Phys; 2010 Jan; 37(1):368-76. PubMed ID: 20175499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of gold shielding on the dosimetry of an 125I seed at close range.
    Wu A; Sternick ES; Muise DJ
    Med Phys; 1988; 15(4):627-8. PubMed ID: 3211059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monte Carlo dosimetry for 103Pd, 125I, and 131Cs ocular brachytherapy with various plaque models using an eye phantom.
    Lesperance M; Martinov M; Thomson RM
    Med Phys; 2014 Mar; 41(3):031706. PubMed ID: 24593710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy.
    Thomson RM; Taylor RE; Rogers DW
    Med Phys; 2008 Dec; 35(12):5530-43. PubMed ID: 19175111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetry for 125I seed (model 6711) in eye plaques.
    Chiu-Tsao ST; Anderson LL; O'Brien K; Stabile L; Liu JC
    Med Phys; 1993; 20(2 Pt 1):383-9. PubMed ID: 8497229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monte Carlo and thermoluminescence dosimetry of the new IsoSeed model I25.S17 125I interstitial brachytherapy seed.
    Lymperopoulou G; Papagiannis P; Sakelliou L; Karaiskos P; Sandilos P; Przykutta A; Baltas D
    Med Phys; 2005 Nov; 32(11):3313-7. PubMed ID: 16370418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity of low energy brachytherapy Monte Carlo dose calculations to uncertainties in human tissue composition.
    Landry G; Reniers B; Murrer L; Lutgens L; Gurp EB; Pignol JP; Keller B; Beaulieu L; Verhaegen F
    Med Phys; 2010 Oct; 37(10):5188-98. PubMed ID: 21089752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymer gel dosimetry close to an 125I interstitial brachytherapy seed.
    Pantelis E; Lymperopoulou G; Papagiannis P; Sakelliou L; Stiliaris E; Sandilos P; Seimenis I; Kozicki M; Rosiak JM
    Phys Med Biol; 2005 Sep; 50(18):4371-84. PubMed ID: 16148399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monte Carlo calculations of dosimetry parameters of the urocor prostaseed 125I source.
    Li Z
    Med Phys; 2002 Jun; 29(6):1029-34. PubMed ID: 12094972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS.
    Chiu-Tsao ST; Astrahan MA; Finger PT; Followill DS; Meigooni AS; Melhus CS; Mourtada F; Napolitano ME; Nath R; Rivard MJ; Rogers DW; Thomson RM
    Med Phys; 2012 Oct; 39(10):6161-84. PubMed ID: 23039655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and dosimetric considerations of a modified COMS plaque: the reusable "seed-guide" insert.
    Astrahan MA; Szechter A; Finger PT
    Med Phys; 2005 Aug; 32(8):2706-16. PubMed ID: 16193802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brachytherapy dosimetry of 125I and 103Pd sources using an updated cross section library for the MCNP Monte Carlo transport code.
    Bohm TD; DeLuca PM; DeWerd LA
    Med Phys; 2003 Apr; 30(4):701-11. PubMed ID: 12722822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of new GAFCHROMIC EBT film for 125I seed dosimetry in Solid Water phantom.
    Chiu-Tsao ST; Medich D; Munro J
    Med Phys; 2008 Aug; 35(8):3787-99. PubMed ID: 18777938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multigroup discrete ordinates modeling of 125I 6702 seed dose distributions using a broad energy-group cross section representation.
    Daskalov GM; Baker RS; Rogers DW; Williamson JF
    Med Phys; 2002 Feb; 29(2):113-24. PubMed ID: 11871380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The exposure rate constant for a silver wire 125I seed.
    Hashemi AM; Mills MD; Hogstrom KR; Almond PR
    Med Phys; 1988; 15(2):228-34. PubMed ID: 3386595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric characteristics of the DRAXIMAGE model LS-1 1-125 interstitial brachytherapy source design: a Monte Carlo investigation.
    Williamson JF
    Med Phys; 2002 Apr; 29(4):509-21. PubMed ID: 11991122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of the intrinsic energy dependence of LiF:Mg,Ti thermoluminescent dosimeters for 125I and 103Pd brachytherapy sources relative to 60Co.
    Reed JL; Rasmussen BE; Davis SD; Micka JA; Culberson WS; DeWerd LA
    Med Phys; 2014 Dec; 41(12):122103. PubMed ID: 25471976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose rate determination for 125I seeds.
    Chiu-Tsao ST; Anderson LL; O'Brien K; Sanna R
    Med Phys; 1990; 17(5):815-25. PubMed ID: 2233567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.